Improved quality control of [177Lu]Lu-PSMA I&T

被引：0
|
作者：
Martin Kraihammer
Piotr Garnuszek
Andreas Bauman
Michael Maurin
Manuel Alejandre Lafont
Roland Haubner
Elisabeth von Guggenberg
Michael Gabriel
Clemens Decristoforo
机构：
[1] Medical University Innsbruck,Department of Nuclear Medicine
[2] Kepler University Hospital,Department of Nuclear Medicine and Endocrinology
[3] National Centre for Nuclear Research,Radioisotope Centre POLATOM
[4] University Hospital Basel,Division of Radiopharmaceutical Chemistry
来源：
EJNMMI Radiopharmacy and Chemistry | / 8卷
关键词：
PSMA; [; Lu]Lu-PSMA I&T; Zadavotide guraxetan; Radionuclide therapy; Quality control; HPLC; TLC; Validation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Improved quality control of [177Lu]Lu-PSMA I&T
    Kraihammer, Martin
    Garnuszek, Piotr
    Bauman, Andreas
    Maurin, Michael
    Lafont, Manuel Alejandre
    Haubner, Roland
    von Guggenberg, Elisabeth
    Gabriel, Michael
    Decristoforo, Clemens
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [2] Optimising the Synthesis and QC of [177Lu]Lu-PSMA I&T for Prostate Cancer Therapy
    Hong, K.
    Fincher, L.
    Browne, E.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 53 - 54
  • [3] Identification of [177Lu]Lu-PSMA I&T, [177Lu]LuCl3 and [177Lu] Lu-DTPA by a single reversed-phase TLC
    Cucchi, C.
    Bogni, A.
    Mainente, M.
    Beretta, C.
    Kirienko, M.
    Seregni, E.
    Pascali, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S666 - S666
  • [4] Radioligand Therapy with [177Lu]Lu-PSMA I&T in the Elderly - Safety, Efficacy and Prognosticators of Survival
    Weber, S.
    Seitz, A.
    Kuebler, H.
    Buck, A. K.
    Werner, R. A.
    Hartrampf, P. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S151 - S151
  • [5] [177LU]LU-PSMA I&T: DEVELOPMENT OF A MULTIPLE-PATIENT DOSE PRODUCTION METHOD
    Walker, A.
    Rivinoja, D.
    Zia, N.
    Seale, J.
    Santamaria, J.
    Santamaria, G.
    Lengkeek, N.
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 35 - 35
  • [6] Quantifying the impact of residual activity on therapeutic index: an updated dosimetric comparison between [177Lu]Lu-PSMA-10.1 and [177Lu]Lu-PSMA I&T
    Rinscheid, A.
    Dierks, A.
    Kircher, M.
    Pfob, C.
    Bundschuh, R. A.
    Lapa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S811 - S812
  • [7] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Philipp E. Hartrampf
    Franz-Xaver Weinzierl
    Andreas K. Buck
    Steven P. Rowe
    Takahiro Higuchi
    Anna Katharina Seitz
    Hubert Kübler
    Andreas Schirbel
    Markus Essler
    Ralph A. Bundschuh
    Rudolf A. Werner
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3269 - 3276
  • [8] Matched-pair analysis of [177Lu]Lu-PSMA I&T and [177Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Buck, Andreas K.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Schirbel, Andreas
    Essler, Markus
    Bundschuh, Ralph A.
    Werner, Rudolf A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3269 - 3276
  • [9] Hematotoxicity and Nephrotoxicity in Prostate Cancer Patients Undergoing Radioligand Therapy with [177Lu]Lu-PSMA I&T
    Hartrampf, Philipp E.
    Weinzierl, Franz-Xaver
    Serfling, Sebastian E.
    Pomper, Martin G.
    Rowe, Steven P.
    Higuchi, Takahiro
    Seitz, Anna Katharina
    Kuebler, Hubert
    Buck, Andreas K.
    Werner, Rudolf A.
    CANCERS, 2022, 14 (03)
  • [10] Radioligand Treatment with [177Lu]Lu-PSMA I&T in the Older Patients - Safety, Efficacy, and Prognostic Factors for Survival
    Weber, Simon
    Seitz, Anna
    Kuebler, Hubert
    Buck, Andreas
    Werner, Rudolf
    Hartrampf, Philipp
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
12345